Quick Answer
Phathom Pharmaceuticals, Inc. reported Net Income of -$221.25 million for fiscal year 2025.
Phathom Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$221.25M | +33.8% |
| 2024 | -$334.33M | -65.8% |
| 2023 | -$201.59M | -2.0% |
| 2022 | -$197.72M | -37.4% |
| 2021 | -$143.88M | -11.5% |
| 2020 | -$129.07M | +49.4% |
| 2019 | -$255.13M | -19708.3% |
| 2018 | -$1.29M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$29.97M | +65.0% | +60.5% |
| June 30, 2025 | -$75.81M | +17.1% | +19.6% |
| March 31, 2025 | -$94.32M | -13.8% | -10.2% |
| September 30, 2024 | -$85.58M | -97.9% | +6.4% |
| June 30, 2024 | -$91.45M | -123.2% | -10.4% |
| March 31, 2024 | -$82.85M | -119.1% | -91.6% |
| September 30, 2023 | -$43.24M | +15.4% | -5.6% |
| June 30, 2023 | -$40.97M | +19.6% | -8.3% |
- Phathom Pharmaceuticals, Inc. showed an increase of +33.8% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Phathom Pharmaceuticals, Inc.’s net income has declined by 17077.6% (from -$1.29 million to -$221.25 million).
- The most recent figure is from Phathom Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: